269 related articles for article (PubMed ID: 17575572)
21. A rapid alternative to X-ray crystallography for chiral determination: case studies of vibrational circular dichroism (VCD) to advance drug discovery projects.
Wesolowski SS; Pivonka DE
Bioorg Med Chem Lett; 2013 Jul; 23(14):4019-25. PubMed ID: 23743289
[TBL] [Abstract][Full Text] [Related]
22. Bioinspired interactions studied by vibrational circular dichroism.
Urbanová M
Chirality; 2009; 21 Suppl 1():E215-30. PubMed ID: 19937957
[TBL] [Abstract][Full Text] [Related]
23. Elucidation of the absolute configuration of rhizopine by chiral supercritical fluid chromatography and vibrational circular dichroism.
Krief A; Dunkle M; Bahar M; Bultinck P; Herrebout W; Sandra P
J Sep Sci; 2015 Jul; 38(14):2545-50. PubMed ID: 25931280
[TBL] [Abstract][Full Text] [Related]
24. A qualitative model for the histamine H3 receptor explaining agonistic and antagonistic activity simultaneously.
de Esch IJ; Timmerman H; Menge WM; Nederkoorn PH
Arch Pharm (Weinheim); 2000 Aug; 333(8):254-60. PubMed ID: 11008375
[TBL] [Abstract][Full Text] [Related]
25. The determination of the absolute configurations of chiral molecules using vibrational circular dichroism (VCD) spectroscopy.
Stephens PJ; Devlin FJ; Pan JJ
Chirality; 2008 May; 20(5):643-63. PubMed ID: 17955495
[TBL] [Abstract][Full Text] [Related]
26. Determination of the absolute configuration of a chiral oxadiazol-3-one calcium channel blocker, resolved using chiral chromatography, via concerted density functional theory calculations of its vibrational circular dichroism, electronic circular dichroism, and optical rotation.
Stephens PJ; Devlin FJ; Gasparrini F; Ciogli A; Spinelli D; Cosimelli B
J Org Chem; 2007 Jun; 72(13):4707-15. PubMed ID: 17516678
[TBL] [Abstract][Full Text] [Related]
27. Development of a selective and potent radioactive ligand for histamine H(3) receptors: A compound potentially useful for receptor occupancy studies.
Mitobe Y; Ito S; Mizutani T; Nagase T; Sato N; Tokita S
Bioorg Med Chem Lett; 2009 Aug; 19(15):4075-8. PubMed ID: 19553110
[TBL] [Abstract][Full Text] [Related]
28. A scalable synthesis of a histamine H3 receptor antagonist.
Mani NS; Jablonowski JA; Jones TK
J Org Chem; 2004 Nov; 69(23):8115-7. PubMed ID: 15527300
[TBL] [Abstract][Full Text] [Related]
29. Absolute configuration and conformation analysis of 1-phenylethanol by matrix-isolation infrared and vibrational circular dichroism spectroscopy combined with density functional theory calculation.
Shin-ya K; Sugeta H; Shin S; Hamada Y; Katsumoto Y; Ohno K
J Phys Chem A; 2007 Sep; 111(35):8598-605. PubMed ID: 17685495
[TBL] [Abstract][Full Text] [Related]
30. Absolute configuration of verticillane diterpenoids by vibrational circular dichroism.
Cerda-García-Rojas CM; García-Gutiérrez HA; Hernandez-Hernandez JD; Roman-Marín LU; Joseph-Nathan P
J Nat Prod; 2007 Jul; 70(7):1167-72. PubMed ID: 17583951
[TBL] [Abstract][Full Text] [Related]
31. Transformation of the amyloidogenic peptide amylin(20-29) into its corresponding peptoid and retropeptoid: access to both an amyloid inhibitor and template for self-assembled supramolecular tapes.
Elgersma RC; Mulder GE; Kruijtzer JA; Posthuma G; Rijkers DT; Liskamp RM
Bioorg Med Chem Lett; 2007 Apr; 17(7):1837-42. PubMed ID: 17276062
[TBL] [Abstract][Full Text] [Related]
32. Determination of the absolute configuration of a key tricyclic component of a novel vasopressin receptor antagonist by use of vibrational circular dichroism.
Dyatkin AB; Freedman TB; Cao X; Dukor RK; Maryanoff BE; Maryanoff CA; Matthews JM; Shah RD; Nafie LA
Chirality; 2002; 14(2-3):215-9. PubMed ID: 11835568
[TBL] [Abstract][Full Text] [Related]
33. The Bip method, based on the induced circular dichroism of a flexible biphenyl probe in terminally protected -Bip-Xaa*- dipeptides, for assignment of the absolute configuration of beta-amino acids.
Dutot L; Wright K; Gaucher A; Wakselman M; Mazaleyrat JP; De Zotti M; Peggion C; Formaggio F; Toniolo C
J Am Chem Soc; 2008 May; 130(18):5986-92. PubMed ID: 18399631
[TBL] [Abstract][Full Text] [Related]
34. Conformational analysis of chiral helical perfluoroalkyl chains by VCD.
Monde K; Miura N; Hashimoto M; Taniguchi T; Inabe T
J Am Chem Soc; 2006 May; 128(18):6000-1. PubMed ID: 16669645
[TBL] [Abstract][Full Text] [Related]
35. Dibasic non-imidazole histamine H3 receptor antagonists with a rigid biphenyl scaffold.
Morini G; Comini M; Rivara M; Rivara S; Lorenzi S; Bordi F; Mor M; Flammini L; Bertoni S; Ballabeni V; Barocelli E; Plazzi PV
Bioorg Med Chem Lett; 2006 Aug; 16(15):4063-7. PubMed ID: 16713264
[TBL] [Abstract][Full Text] [Related]
36. Novel histamine H3 receptor antagonists based on the 4-[(1H-imidazol-4-yl)methyl]piperidine scaffold.
Vaccaro WD; Sher R; Berlin M; Shih NY; Aslanian R; Schwerdt JH; McCormick KD; Piwinski JJ; West RE; Anthes JC; Williams SM; Wu RL; She HS; Rivelli MA; Mutter JC; Corboz MR; Hey JA; Favreau L
Bioorg Med Chem Lett; 2006 Jan; 16(2):395-9. PubMed ID: 16246552
[TBL] [Abstract][Full Text] [Related]
37. VCD spectroscopic investigation of enantiopure cyclic beta-lactams obtained through Lipolase-catalyzed enantioselective ring-opening reaction.
Vass E; Hollósi M; Forró E; Fülöp F
Chirality; 2006 Sep; 18(9):733-40. PubMed ID: 16856169
[TBL] [Abstract][Full Text] [Related]
38. Non-imidazole histamine H3 ligands. Part III. New 4-n-propylpiperazines as non-imidazole histamine H3-antagonists.
Walczyński K; Zuiderveld OP; Timmerman H
Eur J Med Chem; 2005 Jan; 40(1):15-23. PubMed ID: 15642406
[TBL] [Abstract][Full Text] [Related]
39. Determination of molecular stereochemistry using vibrational circular dichroism spectroscopy: absolute configuration and solution conformation of 5-formyl-cis, cis-1,3,5-trimethyl-3-hydroxymethylcyclohexane-1-carboxylic acid lactone.
Izumi H; Futamura S; Nafie LA; Dukor RK
Chem Rec; 2003; 3(2):112-9. PubMed ID: 12731081
[TBL] [Abstract][Full Text] [Related]
40. Spectroscopic methods for determining enantiomeric purity and absolute configuration in chiral pharmaceutical molecules.
Shah RD; Nafie LA
Curr Opin Drug Discov Devel; 2001 Nov; 4(6):764-75. PubMed ID: 11899617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
